공시 • Mar 24
Garden Stage Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement Garden Stage Limited announced that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC on March 20, 2026 notifying the Company that it has regained compliance with the Nasdaq Capital Market’s minimum bid price requirement and that the matter is now closed. On September 5, 2025, the Company was first notified by Nasdaq of its failure to maintain a minimum closing bid price of at least $1.00 per share for 30 consecutive trading days under Nasdaq Listing Rule 5550(a)(2), and was given 180 calendar days, or until March 4, 2026, to regain compliance. On March 5, 2026, the Company received an additional 180-day extension from Nasdaq, or until September 1, 2026, to regain compliance. On March 6, 2026, the Company effected a share consolidation pursuant to which the authorised, issued and outstanding Class A ordinary shares of the Company were consolidated at 200 for 1 ratio. The Notice noted that as of March 20, 2026, the closing bid price of Class A ordinary shares of the Company had been at or greater than $1.00 per share from March 6, 2026 through March 19, 2026. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), and Nasdaq considers the matter closed. New Risk • Mar 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 53% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 16x increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (US$23.9m market cap). Reported Earnings • Jan 22
First half 2026 earnings released: US$0.11 loss per share (vs US$0.21 loss in 1H 2025) First half 2026 results: US$0.11 loss per share. Net loss: US$6.49m (loss widened 98% from 1H 2025). 공시 • Sep 17
Garden Stage Limited has filed a Follow-on Equity Offering in the amount of $4.9 million. Garden Stage Limited has filed a Follow-on Equity Offering in the amount of $4.9 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 144,117,647
Price\Range: $0.034
Discount Per Security: $0
Transaction Features: Registered Direct Offering Reported Earnings • Aug 01
Full year 2025 earnings released: US$0.28 loss per share (vs US$0.34 loss in FY 2024) Full year 2025 results: US$0.28 loss per share (improved from US$0.34 loss in FY 2024). Net loss: US$4.32m (loss narrowed 5.9% from FY 2024). 공시 • Jul 26
Garden Stage Limited has completed a Follow-on Equity Offering in the amount of $4.225512 million. Garden Stage Limited has completed a Follow-on Equity Offering in the amount of $4.225512 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 35,553,820
Price\Range: $0.11
Discount Per Security: $0.0088
Security Name: Pre-funded Warrants
Security Type: Equity Warrant
Securities Offered: 2,862,525
Price\Range: $0.1099
Discount Per Security: $0.0088
Transaction Features: Registered Direct Offering 공시 • Jul 25
Garden Stage Limited has filed a Follow-on Equity Offering. Garden Stage Limited has filed a Follow-on Equity Offering.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 38,406,345
Price\Range: $0.11
Security Name: Pre-funded Warrants
Security Type: Equity Warrant
Transaction Features: Registered Direct Offering New Risk • Jul 22
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$7.84m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (34% average weekly change). Earnings have declined by 74% per year over the past 5 years. Shareholders have been substantially diluted in the past year (128% increase in shares outstanding). Market cap is less than US$10m (US$7.84m market cap). Minor Risk Revenue is less than US$5m (US$1.3m revenue). New Risk • May 09
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 51% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 74% per year over the past 5 years. Shareholders have been substantially diluted in the past year (51% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (US$1.3m revenue). Market cap is less than US$100m (US$10.3m market cap). 공시 • Apr 10
Garden Stage Limited has filed a Follow-on Equity Offering in the amount of $0.990001 million. Garden Stage Limited has filed a Follow-on Equity Offering in the amount of $0.990001 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 3,193,550
Price\Range: $0.31
Discount Per Security: $0 공시 • Apr 09
Garden Stage Limited has filed a Follow-on Equity Offering in the amount of $1.49 million. Garden Stage Limited has filed a Follow-on Equity Offering in the amount of $1.49 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 4,806,450
Price\Range: $0.31
Discount Per Security: $0 New Risk • Feb 08
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 26% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$8.3m free cash flow). Share price has been highly volatile over the past 3 months (26% average weekly change). Earnings have declined by 74% per year over the past 5 years. Market cap is less than US$10m (US$6.91m market cap). Minor Risk Revenue is less than US$5m (US$1.3m revenue). Reported Earnings • Jan 27
First half 2025 earnings released: US$0.21 loss per share (vs US$0.06 loss in 1H 2024) First half 2025 results: US$0.21 loss per share (further deteriorated from US$0.06 loss in 1H 2024). Net loss: US$3.27m (loss widened 336% from 1H 2024). New Risk • Dec 03
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$9.63m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$7.1m free cash flow). Share price has been highly volatile over the past 3 months (79% average weekly change). Revenue has declined by 57% over the past year. Market cap is less than US$10m (US$9.63m market cap). Minor Risks Shareholders have been diluted in the past year (2.5% increase in shares outstanding). Revenue is less than US$5m (US$1.4m revenue). New Risk • Sep 13
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 26% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$7.1m free cash flow). Share price has been highly volatile over the past 3 months (26% average weekly change). Revenue has declined by 57% over the past year. Minor Risk Revenue is less than US$5m (US$1.4m revenue). New Risk • Aug 14
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$94.1m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$7.1m free cash flow). Revenue has declined by 57% over the past year. Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (US$1.4m revenue). Market cap is less than US$100m (US$94.1m market cap). Reported Earnings • Aug 01
Full year 2024 earnings released: US$0.34 loss per share (vs US$0.018 loss in FY 2023) Full year 2024 results: US$0.34 loss per share (further deteriorated from US$0.018 loss in FY 2023). Net loss: US$4.59m (loss widened US$4.38m from FY 2023). 공시 • Apr 05
Garden Stage Limited Announces CFO Changes On April 1, 2024, the Board of Directors of Garden Stage Limited accepted the resignation of Mr. Ting Hei Lee as the Chief Financial Officer of the Company, which came into effect the same day. Mr. Lee is resigning for personal reasons and his decision to resign was not as a result of any disagreements with the Board of the Company on any matter. In connection with Mr. Lee’s resignation, the Company announced that it has appointed Mr. Sze Ho Chan as the Interim Chief Financial Officer of the Company. The Board and the Nominating Committee approved the appointment of Mr. Chan as Interim CFO, succeeding Mr. Lee. A global search for a new Chief Financial Officer is underway. Set forth below is certain biographical information regarding the background and experience of Mr. Sze Ho Chan: Mr. Sze Ho Chan is a Director and Chief Executive Officer of the Company. Mr. Chan also serves as the Director of I Win Securities. Mr. Chan is licensed as the Responsible Officer for Type 1 regulated activities. Mr. Chan has more than 11 years of experience in the financial services industry, covering the area of margin financing, securities trading, asset management, and wealth management. Prior to joining I Win Securities in December 2020, Mr. Chan worked in the Wealth Management division of CMBC Securities Company Limited, as its Senior Manager, from January 2018 to July 2020. Prior to joining CMBC Securities Company Limited, Mr. Chan served as the Manager of the Wealth Management division of CITICS Securities International, from July 2011 to July 2017. Mr. Chan received a Bachelor of Construction Engineering and Management from the City University of Hong Kong in 2010 and a High Diploma in Building Technology and Management from the Hong Kong Polytechnic University in 2007. Reported Earnings • Mar 29
First half 2024 earnings released First half 2024 results: US$0.06 loss per share. Net loss: US$751.7k (flat on 1H 2023). New Risk • Mar 28
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$92.5m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (20% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Revenue is less than US$5m (US$3.3m revenue). Market cap is less than US$100m (US$92.5m market cap). New Risk • Jan 16
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Revenue is less than US$5m (US$3.3m revenue). Board Change • Dec 01
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.